[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018; 68:7-30.
[2] Morgan Rouprêt, Marko Babjuk, Eva Compérat, Richard Zigeuner, Richard J. Sylvester,
Maximilian Burger, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update[J]. European Urology, 2018, 73: 111-122.
[3] Roscigno M, Brausi M, Heidenreich A, et al. Lymphadenectomy at the Time of Nephroureterectomy for Upper Tract Urothelial Cancer[J]. European Urology, 2011, 60(4): 776-783.
[4] Lughezzani G, Jeldres C, Isbarn H, et al. A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma[J]. Urology, 2010, 75(1): 118-124.
[5] Dominguez-Escrig J L, Peyronnet B, Seisen T, et al. Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer[J]. European Urology Focus, 2017, 17(2): e1721.
[6] Thurairaja R, Studer UE, Burkhard FC. Indications, extent, and benefits of pelvic lymph node dissection for patients with bladder and prostate cancer[J]. Oncologist 2009; 14: 40-51.
[7] Moschini M, Foerster B, Abufaraj M, et al. Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy[J]. World Journal of Urology, 2017, 35(10): 1541-1547.
[8] Abdollah F, Sun M, Schmitges J, et al. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy[J]. BJU International, 2012, 109(8):1147-1154.
[9] Chappidi M R, Kates M, Johnson M H, et al. Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012) [J]. Urologic Oncology Seminars & Original Investigations, 2016, 34(12).
[10] Inokuchi Junichi, Eto Masatoshi, Hara Tomohiko, et al. Impact of lymph node dissection on clinical outcomes during nephroureterectomy in patients with clinically node-negative upper urinary tract urothelial cancer: subanalysis of a multi-institutional nationwide case series of the Japanese Urological Association[J]. Japanese Journal of Clinical Oncology, 2017, 47: 652-659.
[11] Ikeda Masaomi, Matsumoto Kazumasa, Sakaguchi Kazushige, et al. Effect of Lymphadenectomy During Radical Nephroureterectomy in Locally Advanced Upper Tract Urothelial Carcinoma[J]. Clinical Genitourinary Cancer, 2017, 15: 556-562.
[12] Inokuchi Junichi, Kuroiwa Kentaro, Kakehi Yoshiyuki, et al. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A[J]. World Journal of Urology, 2017, 35: 1737-1744.
[13] Fan Dong, Tianyuan Xu, Xianjin Wang, et al. Lymph node dissection could bring survival benefits to patients diagnosed with clinically node-negative upper urinary tract urothelial cancer: a population-based, propensity score-matched study[J]. International Journal of Clinical Oncology, 2019, 24: 296-305.
[14] Gschwend Jürgen E, Heck Matthias M, Lehmann Jan, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial[J]. European Urology, 2019, 75: 604-611.
[15] Nocera Luigi, Sood Akshay, Dalela Deepansh, et al. Rate and Extent of Pelvic Lymph Node Dissection in the US Prostate Cancer Patients Treated with Radical Prostatectomy[J]. Clinical Genitourinary Cancer, 2018, 16: e451-e467.
[16] Nazzani Sebastiano, Mazzone Elio, Preisser Felix, et al. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma[J]. European Journal of Surgical Oncology, 2018, DOI: 10.1016/j.ejso.2018.12.004.
[17] Zareba Piotr, Rosenzweig Barak, Winer Andrew G, et al. Association between lymph node yield and survival among patients undergoing radical nephroureterectomy for urothelial carcinoma of the upper tract[J]. Cancer, 2017, 123: 1741-1750.
[18] Winer Andrew G, Vertosick Emily A, Ghanaat Mazyar, et al. Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma[J]. Urologic Oncology Seminars & Original Investigations, 2017, 35: 151.e9-151.e15.
[19] Lughezzani Giovanni, Jeldres Claudio, Isbarn Hendrik, et al. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma[J]. Urology, 2010, 75: 118-24.
[20] Messer Jamie, Lin Yu Kuan, Raman Jay D. The role of lymphadenectomy for upper tract urothelial carcinoma[J]. Nature Reviews Urology, 2011, 8: 394-401.
[21] Burger Maximilian, Shariat Shahrokh F, Fritsche Hans-Martin, et al. No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study[J]. World Journal of Urology, 2011, 29: 465-72.
[22] Seisen Thomas, Shariat Shahrokh F, Cussenot Olivier, et al. Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma[J]. World Journal of Urology, 2017, 35: 535-548.